OQO

Herpes Simplex Virus Nucleic Acid Amplification Assay

Product code
OQO
Device name
Herpes Simplex Virus Nucleic Acid Amplification Assay
Device class
Class 2
21 CFR
21 CFR 866.3305
Medical specialty
Microbiology
Marketing pathway
510(K)
510(k) clearances (all years, FDA)
12 (all years; only the last 3 years are listed here)

FDA classification definition

A polymerase chain reaction (pcr)-based qualitative in vitro diagnostic test for the detection and typing of herpes simplex virus (hsv) dna using vaginal swab specimens.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: OQO
Classification and pathway per current FDA publications. Data from openFDA (CC0).